Ocariza, Kakashca Faye L.
HRN: 24-37-13 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/05/2024
CEFTRIAXONE 1G (VIAL)
01/05/2024
01/11/2024
IV
800mg
OD
PCAP Severe
Waiting Final Action